Safety and effectiveness of once-yearly zoledronic acid in Japanese osteoporosis patients: three-year post-marketing surveillance

ConclusionThis 3-year post-marketing surveillance confirmed the real-world safety and effectiveness of ZOL.
Source: Journal of Bone and Mineral Metabolism - Category: Orthopaedics Source Type: research